Screener
Ligand Pharmaceuticals LGND Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
| Proceeds from Pelthos investors | — | 6,910 |
| Net cash provided by financing activities | 532,301 | 10,248 |
| Effect of exchange rate changes on cash and cash equivalents | (5) | 3,350 |
| Net increase (decrease) in cash, cash equivalents and restricted cash, including cash and cash equivalents classified within assets held for sale | 831,775 | (1,821) |
| Less: net increase in cash and cash equivalents classified within assets held for sale | — | (2,817) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 831,775 | (4,638) |
| Cash, cash equivalents and restricted cash at beginning of period | 174,927 | 72,307 |
| Cash, cash equivalents and restricted cash at end of period | $1,006,702 | $67,669 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ligand Pharmaceuticals's net change in cash?
- Ligand Pharmaceuticals (LGND) reported net change in cash of $891.61M in Q2 2026.
- How has Ligand Pharmaceuticals's net change in cash changed year-over-year?
- Ligand Pharmaceuticals's net change in cash increased by 4430.5% year-over-year, from $19.68M to $891.61M.
- What is the long-term trend for Ligand Pharmaceuticals's net change in cash?
- Over 3 years (2021 to 2025), Ligand Pharmaceuticals's net change in cash has grown at a 50.9% compound annual growth rate (CAGR), from -$29.86M to $102.62M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Ligand Pharmaceuticals's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude